Literature DB >> 19727269

Performance-Enhancing Drugs: Where Should the Line be Drawn and by Whom?

Michael T Lardon1.   

Abstract

The integrity of sport is predicated on the assumption that all athletes compete on a level playing field. Unfortunately, the use and abuse of performance-enhancing drugs has become ubiquitous, creating complex challenges for the governing bodies of individual sports. This article examines the complexity of these issues within the world of professional golf, major league baseball, and Olympic competition. Integral concepts like, "What is a therapeutic exemption?" and "When does restorative function end and performance enhancement begin?" are discussed in detail.

Keywords:  governing body; performance-enhancing drugs; restorative function; therapeutic exemption

Year:  2008        PMID: 19727269      PMCID: PMC2695732     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  9 in total

Review 1.  A practical approach to the overtraining syndrome.

Authors:  P Z Pearce
Journal:  Curr Sports Med Rep       Date:  2002-06       Impact factor: 1.733

2.  Should psychologists have prescribing authority?

Authors:  Deanna F Yates; Jack G Wiggins; Jeremy A Lazarus; James H Scully; Michelle Riba
Journal:  Psychiatr Serv       Date:  2004-12       Impact factor: 3.084

Review 3.  Interviewing principles for the psychiatrically aware sports medicine physician.

Authors:  Ronald L Kamm
Journal:  Clin Sports Med       Date:  2005-10       Impact factor: 2.182

Review 4.  beta-Adrenoceptor blockade and exercise: effects on endurance and physical training.

Authors:  A Juhlin-Dannfelt
Journal:  Acta Med Scand Suppl       Date:  1983

Review 5.  Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete.

Authors:  David O Conant-Norville; Ian R Tofler
Journal:  Clin Sports Med       Date:  2005-10       Impact factor: 2.182

Review 6.  Mental disorders in primary care: epidemiologic, diagnostic, and treatment research directions.

Authors:  H C Schulberg; B J Burns
Journal:  Gen Hosp Psychiatry       Date:  1988-03       Impact factor: 3.238

7.  Blood doping : infusions, erythropoietin and artificial blood.

Authors:  E Randy Eichner
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

8.  Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.

Authors:  Stefan Begré; Martin Traber; Martin Gerber; Roland von Känel
Journal:  Eur Psychiatry       Date:  2008-03-06       Impact factor: 5.361

9.  beta-Blockade used in precision sports: effect on pistol shooting performance.

Authors:  P Kruse; J Ladefoged; U Nielsen; P E Paulev; J P Sørensen
Journal:  J Appl Physiol (1985)       Date:  1986-08
  9 in total
  1 in total

Review 1.  Treating the elite athlete: anti-doping information for the health professional.

Authors:  Shikha Tandon; Larry D Bowers; Matthew N Fedoruk
Journal:  Mo Med       Date:  2015 Mar-Apr
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.